Table 3 Multivariate analysis of prognostic factors in all patients (N = 216)

Time of VTE occurrence (early vs. late and no VTE)

Khorana score (high-risk vs. intermediate-risk)

ECOG PS (2–3 vs 0–1)

NLR (≥2.7 vs. < 2.7)

PLR (≥180 vs. < 180)

WBC (≥11,000 /μLvs. <11,000 /μL)

Hb (< 10 g/dL vs. ≥10 g/dL)

Na (< 135 mmol/L vs. ≥135 mmol/L)

Albumin (< 3.5 g/dL vs. ≥3.5 g/dL)

CA19–9 (≥1000 U/mL vs. < 1000 U/mL)

Liver metastases (Yes vs. No)

Number of metastatic organs (≥3 vs. < 3)